Atlas FDA

LOTUS Edge Valve System

FDA premarket approval P180029/S020 · decided 2020-08-17

Approval details

PMA number
P180029
Supplement
S020
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LOTUS Edge Valve System
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
Boston Scientific Corporation
Date received
2020-03-02
Decision date
2020-08-17
Days to decision
168 days
Decision code
APPR
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
Marborough, MA
Statement
Approval for implementation of a Visual Standard to aid operators in distinguishing between acceptable and rejectable surface defects on the Multi-Lumen Extrusion (MLE) of the Lotus Edge Valve System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27